International Network of VENous Thromboembolism Clinical Research Networks

SAVER/SPIRIT

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism: A Pilot Study Assessing Feasibility of an RCT to Evaluate if Generic Rosuvastatin Reduces the Risk of Recurrent VTE in Patients With Symptomatic Major VTE

Registration:

(Clinicaltrials.gov) NCT02679664

Status:

  • Pilot trial recruiting in Canada and Norway
  • Seeking sites and collaborators for the full trial

Design

Randomized open-label pilot study to determine the feasibility of recruitment to a trial of rosuvastatin vs. no rosuvastatin for secondary prevention of VTE and determine if rosuvastatin can reduce post-thrombotic syndrome

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Canada, Norway

Lead Investigators

Dr. Marc Rodger, MD, MSc

MRodger@toh.ca

Dr. Waleed Ghanima, MD, PhD

wghanima@gmail.com

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.